Gene | Fold diff. | Effect | Ref |
---|---|---|---|
Cytochrome C oxidase iso-1/iso-2 | 1.51 | Libman-Sacks endocarditis and antiphospholipid syndrome (aPLs) | |
Complement factor H-related protein 2 | 1.43 | Libman-Sacks endocarditis and antiphospholipid syndrome (aPLs) | |
Myosin light chain (ELC / RLC) | 1.94/1.3 | Increase in cardiomyocyte size and number, resulting in a larger ventricular chamber volume/reduction in size and number of cardiomyocytes | |
ATP synthase subunit S | 1.47 | Cellular ATP synthesis; depletion of the cellular ATP pool during ischemia | |
GADD45 beta | 1.56 | Cell-cycle control; Somitogenesis abnormalities | [47] |
Inositol polyphosphate multikinase (IPMK) | 1.66 | mRNA export, transcriptional regulation, and chromatin remodeling | [51] |
Phosphatidylinositol phosphate kinase 4 (PIPK) beta | 2.25 | Mouse embryo brain expression (cerebral ventricular and mantle zones) during normal development; postnatal brain gray matter expression | [47] |
Fumarate hydratase (fumarase) | 1.77 | Severe neurologic fetal brain abnormalities, poor feeding, failure to thrive; hypotonia, severe mental retardation, unusual facial features, brain malformation, epileptic seizures |